References
: Abbas, Z. and Afzal, R. (2013). Life cycle and pathogenesis of hepatitis D virus?: A review Life cycle and pathogenesis of hepatitis D virus: A review. World Journal of Hepatology, 5(12):666–675. Akaiwa, M., Yae, Y., Sugimoto, R., Suzuki, S.O., Iwaki, T., Izuhara, K. and Hamasaki, N. (1999). Hakata antigen, a new member of the ficolins/Opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and ile. Journal of Histochemistry and Cytochemistry,6:777-786. Attia, F., Megahed, K. and Zhou, X. (2020). The Interactions Between HBV and the Innate Immunity of Hepatocytes. Viruses, 12(285):1–14. Banchereau, J., Briere, F. Caux, C., Davoust, J., Lebecque, S. and Liu, Y. (2000). Immunology of dendritic cells. Annual Review Immunology, 18:767-811. Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J.M., Toscano, M.A., Bianco, G.A., Isturiz, M.A. and Rabinovich, G.A. (2007). A novel function for galectin-1 at the crosssoad of innate and adaptive immunity. Journal of Hepatology, 4:45-6. Bertoletti, A. and Gehring, A. J. (2006). The immune response during hepatitis B virus infection. Journal of General Virology, 87(20):1439–1449. Buti, M. and Razavi, H. (2017). Hepatitis C virus infection. Nature Reviews Disease Primers, 3(17006):1–20. Bayry, J., Lacroix-Desmazes, S., Kazatchkine, M.D., Hermine, O., Tough, D.F. and Kaveri, S.V. (2005). Modulation of dendritic cells maturation and function by B lymphocyte. Journal of Immunology,175:15-20. CDC. (2020). Hepatitis A. U.S. Department of Health and Human Services. Www.cdc.gov/hepatitis. 21-24. CDC. (2012). Hepatitis C virus ( HCV ). In www.cdc.gov/ncidod/diseases/hepatitis/c. Contact,302:744–1050. Www.cdc.gov/ncidod/diseases/hepatitis/c.Contact. Cerwenka, A., and Lanier, L.L. (2001). Natural killer cells, viruses and cancer. Natures Review Immunolog,. 1:41-9. Cross, A.S. (2009). What is a virulence factor? Critical Care, 12(6). Https://doi.org/10.1186/cc7127 Cruvinel, W.D., Melo, D., Mesquita, J., Julio, A., Pereira A., Tânia, T. and Takao, C. (2010). “Fundamentals of Innate Immunity with.” Brasilian Journal of Rheumatol 55 (11):1– Dranoff, D. (2004). Lecture 1 - Innate Immune System. Natures Reviews Cancer, 4:11–22. Faure, S., Lucifora, J., and Durantel, D. (2017). Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts. Viruses, 9(95):1–21. Fayer, R., Orlandi, P., and Perdue, M. L. (2009). Virulence factor activity relationships for hepatitis E and Cryptosporidium. Journal of Water and Health, 7(1): 55–63. Fitzgerald-Bocarsly, p., and Feng, D. (2007). The role of type I interferon production by dendritic cells in host defense. Biochemistry,89:843-855. Gholamreza, R., Shahryar, S., Abbasali, K., Hamidreza, J., Abdolvahab, M., Khodaberdi, K., Danyal, R. and Nafiseh, A. (2007). Seroprevalence of hepatitis B virus and its co- infection population. Indian Journal of Medical Sciences, 263(264):153–155. Guidotti, L. G. and Chisari, F. V. (2006). Immunobiology and Pathogenesis of Viral Hepatitis. Annual Review of Pathology Mechanisms of Disease, 1:23–61. IOCI. (2008). Hepatitis A. State of lllinois, Department of Public Health.22-24. Iwasaki A. andMedzhitove, R. (2010). Regulation of adaptive immunity by the innate immune system,Science 327:291-295. Khudyakov, Y. (2012). Review Molecular surveillance of hepatitis C. Antiviral Therapy, 17, 1465–1470. Khuroo, M. S., Kamili, S. and Khuroo, M. (2004). Hepatitis E. In R. H. W. B. Al Knawy, M.L. Shiffman (Ed.), Hepatology (Issue November 2014:1–13. Article in press. Https://doi.org/10.13140/2.1.3395.5525 Knolle, P. A. and Thimme, R. (2014). Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection. Gastroenterology, 146(5):1193–1207. s Kumar, V., Das, S. and Jameel, S. (2010). The biology and pathogenesis of hepatitis viruses. Current science, 9(3):1–15. Leikina, E., Delanoe-Ayari, H., Meleikov, K., Chen, A., Waring, A.J., Wang, W., Xie, Y., Loo, J.A. and Lehrer, R.I. (2005). Carbohydrate-binding molecules inhibit viral fusion and entry by cross-linking membrane glycoproteins. Natural immunology, 6:995-1001. Leit, J. H. (2020). Microbial Virulence Factors. Molecular Science, 21:(5320). Lemon, S. M., Ott, J. J., Damme, P. Van, and Shouval, D. (2018). Type A viral hepatitis?: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. Journal of Hepatology, 68(1):167–184. Manns, M.P., and WH, S.P. (2012). Pathogenesis and Treatment of Hepatitis E Virus Infection. Gastroenterology, 142(6): 1388–1397. Margolis, H. S., Alter, M. J., and Hadler, S. C. (2016). Viral Hepatitis. viral hepatitis, 9(2–57). Mark, A. (2018). Liver Disease.Liver cancer, 6:1–21). Metcalf, D.D. (2008). Mast cells and mastocytosis. Blood. 112:946-56. Mizukoshi, E. and Rehermann, B. (2014). Immune responses and immunity in hepatitis C virus infection. Journal of Gastroenterology, 2001(36):799–808. Nainan, O. V., Xia, G., Vaughan, G. and Margolis, H. S. (2006). Diagnosis of Hepatitis A Virus Infection?: A Molecular Approach. Clinical Microbiology Review, 19(1): 63–79. NIH. (2013). Viral Hepatitis C: Introduction. In The NIH clinical trial website, (1–8). The NIH clinical trial website Rehermann, B. and Nascimbeni, M. (2005). Immunology of hepatitis b virus and hepatitis c virus infection.Nature revies/Immunology, 5(215):1–16. Sarowska, J., Koloch, B. F., Kmiecik, A. J., Madrzak, M. F., Ksiazczyk, M., Ploskonska, G.B. and Krol, I. (2019). Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: recent reports. Gut Pathogens, 11(10):1–16. Stockdale, A. J., Kreuels, B., Henrion, M.R., De, C., Hutin, Y. and Geretti, A. M. (2020). The global prevalence of hepatitis D virus infection?: Systematic review and meta-analysis The global prevalence of hepatitis D virus infection. Journal of Hepatology, 73(3), 523– Suslov, A., Boldanova, T., Wang, X., Wieland, S. and Heim, M.H. (2018). Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver. Gastroenterology, 154(6): 1778–1790. Turvey, S. E. and Broide, D.H. (2010). Innate immunity. Journal of Allergy and Clinical Immunology, 125(2):24–32. Vasickova, P., Psikal, I., Kralik, P., Widen, F., Hubalek, Z., and Pavlik, I. (2007). Hepatitis E virus, Veterinarni Medicina, 52(9):365–384. Wang, C., Tschen, S., Heinricy, U., Weber, M. and Flehmig, B. (1996). Immune Response to Hepatitis A Virus Capsid Proteins after Infection. Journal of Clinical Microbiology, 34(3):07–713. Wedemeyer, H. and Manns, M.P. (2010). Epidemiology, pathogenesis and management of hepatitis D?: update and challenges ahead. Nature Reviews Gastroenterology and Hepatology, 7(1):31–40. WHO.(2002). Hepatitis B, Http://www.who.int/emc 23-25. WHO. (2012). Prevention and Control of Viral Hepatitis Infection?: Framework for Global Action, 7:1–28. Www.who.int/topics/hepatitis. Wilson, D.E., Melo, C., Danilo, M.J.,Julio, P.A., Tania, T.K., Alexender, W.S., Neusa, P.S. and Luis, E.A. (2010). Fundamental of innate immunity with emphasis on molecular and cellular mechanisms of inflamatory response Bras. Journal of Rheumatology, 50:434-6.
